Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 2010
Sepsis induces early alterations in innate immunity that impact mortality to secondary infectionMatthew J Delano, Terri Thayer, Sonia Gabrilovich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2018
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant TuberculosisDevyani Deshpande, Jotam G Pasipanodya, Stellah G Mpagama, et al.
Antimicrobial Agents and Chemotherapy|November 5, 2014
Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infectionsSujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2023
Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infectionsDavid Melnick, Angela K Talley, Vipul K Gupta, et al.
Open Forum Infectious Diseases|November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>: Brief SummarySujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2013
Pharmacokinetics-pharmacodynamics of tazobactam in combination with ceftolozane in an in vitro infection modelBrian VanScoy, Rodrigo E Mendes, Anthony M Nicasio, et al.
Open Forum Infectious Diseases|November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>Sujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2011
Neutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signalingMatthew J Delano, Kindra M Kelly-Scumpia, Terri C Thayer, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2016
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection ModelAnthony M Nicasio, Brian D VanScoy, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2023
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzaeSujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
Pageof 17